Characterisation of HBV and SARS-CoV-2 spike specific T cells and their association with viral control

Characterisation of HBV and SARS-CoV-2 spike specific T cells and their association with viral control

<p>T cell responses are crucial in viral clearance, but little is known of the role of cytotoxic CD4+ T cells in the control of viral infection. </p> <p>Chronic hepatitis B virus (HBV) infection is a global public health problem. In the first part of my study, HBx-specific T cell...

Bibliografiset tiedot
Päätekijä:	Liu, G
Muut tekijät:	Dong, T
Aineistotyyppi:	Opinnäyte
Kieli:	English
Julkaistu:	2023
Aiheet:	Infection Immunology

Samankaltaisia teoksia

Computational Investigation of Selected Spike Protein Mutations in SARS-CoV-2: Delta, Omicron, and Some Circulating Subvariants
Tekijä: Urmi Roy
Julkaistu: (2023-12-01)

SARS-CoV-2 infection elucidates features of pregnancy-specific immunity
Tekijä: Dong Sun Oh, et al.
Julkaistu: (2024-11-01)

Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection
Tekijä: Xiao-Lin Jiang, et al.
Julkaistu: (2024-07-01)

Anti-SARS-CoV-2 antibodies in a nasal spray efficiently block viral transmission between ferrets
Tekijä: Kiira Gildemann, et al.
Julkaistu: (2024-07-01)

Characterising the T cell responses to SARS-CoV-2 including variants of concern induced by natural infection and vaccines
Tekijä: Adele, S
Julkaistu: (2024)

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Tekijä: Willett, BJ, et al.
Julkaistu: (2022)

Cross-reactive immunity to SARS-CoV-2 and related coronaviruses
Tekijä: Jay, C
Julkaistu: (2023)

Nonhuman primate antigenic cartography of SARS-CoV-2
Tekijä: Annika Rössler, et al.
Julkaistu: (2025-01-01)

An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike
Tekijä: Banghui Liu, et al.
Julkaistu: (2024-06-01)

Variant- and vaccination-specific alternative splicing profiles in SARS-CoV-2 infections
Tekijä: Sung-Gwon Lee, et al.
Julkaistu: (2024-03-01)

MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodies
Tekijä: Olubukola M. Abiona, et al.
Julkaistu: (2025-02-01)

Studies on immunoreceptor activation and SARS-CoV-2 RBD/ACE2 interactions
Tekijä: Barton, MI
Julkaistu: (2022)

Isolation and identification of SARS-CoV-2 antibodies from COVID-19 patient samples
Tekijä: Liu, C
Julkaistu: (2024)

SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract
Tekijä: Alba Escalera, et al.
Julkaistu: (2024-03-01)

Evolution of protective SARS-CoV-2-specific B and T cell responses upon vaccination and Omicron breakthrough infection
Tekijä: Mohamed I.M. Ahmed, et al.
Julkaistu: (2024-06-01)

Convergence of SARS-CoV-2 spike antibody levels to a population immune setpointResearch in context
Tekijä: Eric J. Nilles, et al.
Julkaistu: (2024-10-01)

Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion
Tekijä: Lu Zhang, et al.
Julkaistu: (2024-06-01)

Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2
Tekijä: Cyril Planchais, et al.
Julkaistu: (2024-07-01)

SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
Tekijä: Jeewandara, C, et al.
Julkaistu: (2021)

Development of an ancestral DC and TLR4-inducing multi-epitope peptide vaccine against the spike protein of SARS-CoV and SARS-CoV-2 using the advanced immunoinformatics approaches
Tekijä: Cena Aram, et al.
Julkaistu: (2024-09-01)

SARS-CoV-2 ferritin nanoparticle vaccines produce hyperimmune equine sera with broad sarbecovirus activity
Tekijä: Elizabeth J. Martinez, et al.
Julkaistu: (2024-10-01)

Elucidating factors of heterogeneous immune response to SARS-CoV-2 and human immunodeficiency virus
Tekijä: Lim, N
Julkaistu: (2024)

SARS-CoV-2 spike S2-specific neutralizing antibodies
Tekijä: Chia-Jung Li, et al.
Julkaistu: (2023-12-01)

SARS-CoV-2 vaccine development and challenges
Tekijä: Duan Fugang, et al.
Julkaistu: (2021-03-01)

A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
Tekijä: Carter, Brandon, et al.
Julkaistu: (2023)

COVID-19 Serum Drives Spike-Mediated SARS-CoV-2 Variation
Tekijä: Yuanling Yu, et al.
Julkaistu: (2024-05-01)

SARS-CoV-2 antigen-carrying extracellular vesicles activate T cell responses in a human immunogenicity model
Tekijä: Sarah E. Cummings, et al.
Julkaistu: (2024-01-01)

Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity
Tekijä: MST Monira Begum, et al.
Julkaistu: (2024-03-01)

Examining the immunoreactivities of the receptor-binding domain of SARS-CoV-2 spike proteins using a panel of human monoclonal antibodies
Tekijä: Tan, Jie Ling
Julkaistu: (2022)

Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1
Tekijä: Alexander Muik, et al.
Julkaistu: (2024-08-01)

Impact of SARS-CoV-2 on Viral Respiratory Infections in Patients with Hematological Malignancies
Tekijä: Antonio Giordano, et al.
Julkaistu: (2024-09-01)

T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination
Tekijä: Samuele Notarbartolo
Julkaistu: (2024-09-01)

Production and characterisation of a SARS-CoV-2 S-protein RBD homodimer with increased avidity for specific antibodies
Tekijä: A. A. Derkaev, et al.
Julkaistu: (2023-04-01)

Differential immunometabolic responses to Delta and Omicron SARS-CoV-2 variants in golden syrian hamsters
Tekijä: Rajesh Rajaiah, et al.
Julkaistu: (2024-08-01)

Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies
Tekijä: Youngchang Kim, et al.
Julkaistu: (2024-02-01)

The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection
Tekijä: Eleonora Vecchio, et al.
Julkaistu: (2024-01-01)

The impact of HLA-driven escape mutation on viral replicative capacity and immune control in HIV infection
Tekijä: Tsai, M
Julkaistu: (2017)

Design and characterization of therapeutic peptides targeting the receptor binding domain of the spike glycoprotein from sars-cov-2
Tekijä: Ho, Chian
Julkaistu: (2023)

Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine
Tekijä: Masayuki Aboshi, et al.
Julkaistu: (2024-02-01)

Direct activation of airway sensory C‐fibers by SARS‐CoV‐2 S1 spike protein
Tekijä: Joyce S. Kim, et al.
Julkaistu: (2023-12-01)